Research output per year
Research output per year
Personal profile
Fields of Science
- 3122 Cancers
International and National Collaboration
Publications and projects within past five years.
-
Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan
Pourjamal, N., Le Joncour, V., Vereb, G., Honkamäki, C., Isola, J., Leyton, J. V., Laakkonen, P., Joensuu, H. & Barok, M., Mar 2025, In: Translational oncology. 53, 9 p., 102284.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial
Yip, D., Zalcberg, J., Blay, J.-Y., Eriksson, M., Espinoza, D., Price, T., Marreaud, S., Italiano, A., Steeghs, N., Boye, K., Underhill, C., Gebski, V., Simes, J., Gelderblom, H. & Joensuu, H., Mar 2025, (E-pub ahead of print) In: British Journal of Cancer. 8 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access -
PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer
Azad, A., Arshad, M., Generali, D., Feldinger, K., Gijsen, M., Strina, C., Cappelletti, M., Andreis, D., Leek, R., Haider, S., Kellokumpu-Lehtinen, P.-L., Roxanis, I., Harris, A. L., Shaaban, A. M., Joensuu, H. & Kong, A., Jan 2025, In: Cancer Communications. 45, 1, p. 68-73 6 p.Research output: Contribution to journal › Article › Scientific
Open AccessFile -
Annotation-efficient deep learning for breast cancer whole-slide image classification using tumour infiltrating lymphocytes and slide-level labels
Perera, R., Savas, P., Senanayake, D., Salgado, R., Joensuu, H., O’Toole, S., Li, J., Loi, S. & Halgamuge, S., 2024, In: Communications Engineering. 3, 1, 11 p., 104.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model
Pourjamal, N., Yazdi, N., Halme, A., Le Joncour, V., Laakkonen, P., Saharinen, P., Joensuu, H. & Barok, M., 2024, In: Clinical and Experimental Metastasis. 41, p. 91–10 12 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
-
Joensuu Jusélius 1/2 2024-25
Joensuu, H. (Project manager) & Barok, M. (Participant)
Sigrid Juséliuksen Säätiö @003701165704@
01/05/2024 → 30/04/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Joensuu/Luise ja Henrik Kuninkaan säätiö
Joensuu, H. (Project manager)
Luise och Henrik Kuningas stiftelse sr c/o H. Kuningas & Co Oy
01/11/2023 → 31/10/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
ProCan: Pro-Canines (=dogs) sniff Prostate Cancer
Hielm-Björkman, A. (Project manager), Paavilainen, S. (Project manager), Mattson, J. (Participant), Joensuu, H. (Principal Investigator), Anturaniemi (o.s. Roine), J. (Participant), Mirtti, T. (Participant), Partanen, P. (Participant) & Rannikko, A. S. (Participant)
Project: Research project
Prizes
-
Fellow of the European Academy of Cancer Sciences
Joensuu, H. (Recipient), 2010
Prize: Prizes and awards
-
-
-
Suomen Syöpäyhdistyksen syöväntorjuntatyön hopeinen ansiomitali
Joensuu, H. (Recipient), 2011
Prize: Prizes and awards
-
The Finnish Medical Foundation 50-year Anniversary Prize
Joensuu, H. (Recipient), 2010
Prize: Prizes and awards
Activities
-
Member of the Editorial Board/Clinical Sarcoma Research (Journal)
Joensuu, H. (Member of editorial board)
2011 → …Activity: Publication peer-review and editorial work types › Editor of research journal
-
13th Annual AGITG Scientific Meeting
Joensuu, H. (Speaker: Keynote)
26 Aug 2011Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
47th Annual Meeting of the American Society of Clinical Oncology.
Joensuu, H. (Speaker: Keynote)
6 Jun 2011Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
3rd Middle East Hematology and Oncology Summit
Joensuu, H. (Speaker: Keynote)
24 Feb 2011 → 25 Feb 2011Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
Otologien ja onkologien vuosikokous
Joensuu, H. (Speaker: Keynote)
20 Jan 2011 → 21 Jan 2011Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
Press/Media
-
-
Final Results of the Collaborative EORTC/Intergroup Randomised Phase III Study of Adjuvant Imatinib in Localised GIST
24/02/2021
1 item of Media coverage
Press/Media: Press / Media
-
AI predicts efficacy of breast cancer treatment directly from tumor architecture
19/02/2021
1 item of Media coverage
Press/Media: Press / Media
-
AI predicts efficacy of breast cancer treatment directly from tumor architecture
17/02/2021 → 18/02/2021
5 items of Media coverage
Press/Media: Press / Media
-
University of Helsinki: Novel Genomic Tools Increase the Accuracy of Breast Cancer Risk Assessment
Kaprio, J., Joensuu, H. & Meretoja, T.
15/12/2020
1 item of Media coverage
Press/Media: Press / Media